Keebeck Alpha, LP Dexcom Inc Transaction History

Keebeck Alpha, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $201,867 - $257,023	1,830 Added 74.15%	4,298 $487,000
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $19,188 - $23,536	168 Added 7.3%	2,468 $342,000
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $11,700 - $19,244	-155 Reduced 6.31%	2,300 $285,000
Q3 2023 Nov 02, 2023	BUY	$86.06 - $137.93 $211,277 - $338,618	2,455 New	2,455 $229,000
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $386,672 - $457,016	3,718 New	3,718 $431,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.